John Hancock Multifactor Developed International ETF (JHMD)
| Assets | $478.49M |
| NAV | $29.72 |
| Expense Ratio | 0.39% |
| PE Ratio | 12.84 |
| Shares Out | 16.10M |
| Dividend (ttm) | $1.08 |
| Dividend Yield | 3.72% |
| Ex-Dividend Date | Dec 27, 2021 |
| 1-Year Return | -15.08% |
| Volume | 16,203 |
| Open | 29.85 |
| Previous Close | 28.92 |
| Day's Range | 28.87 - 29.38 |
| 52-Week Low | 28.09 |
| 52-Week High | 39.75 |
| Beta | 0.83 |
| Holdings | 772 |
| Inception Date | Dec 15, 2016 |
About JHMD
The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities included in the fund's index, in depositary receipts representing securities included in the fund's index and in underlying stocks in respect of depositary receipts included in the fund's index. The index is designed to comprise a subset of securities associated with developed markets outside the U.S. and Canada.
Top 10 Holdings
9.61% of assets| Name | Symbol | Weight |
|---|---|---|
| NESTLE SA-REG | NESN.SW | 1.68% |
| TOYOTA MOTOR CORP | 7203.T | 1.27% |
| ASML HOLDING NV | ASML.AS | 1.04% |
| ROCHE HOLDING AG-GENUSSCHEIN | ROG.SW | 1.02% |
| NOVARTIS AG-REG | NOVN.SW | 0.86% |
| SHELL PLC-NEW /GBP/ | SHEL.L | 0.85% |
| LVMH MOET HENNESSY LOUIS VUI | MC.PA | 0.82% |
| MICHELIN CGDE | ML.PA | 0.70% |
| ORANGE | ORA.PA | 0.69% |
| Novo Nordisk A/S | NOVO B.CO | 0.69% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2021 | $0.51631 | Dec 30, 2021 |
| Jun 25, 2021 | $0.56853 | Jun 30, 2021 |
| Dec 24, 2020 | $0.34966 | Dec 30, 2020 |
| Jun 25, 2020 | $0.23888 | Jun 30, 2020 |
| Dec 24, 2019 | $0.34678 | Dec 30, 2019 |
| Jun 25, 2019 | $0.59725 | Jun 28, 2019 |
News
Multifactor Developed International ETF (JHMD) Hits a 52-Week High
The John Hancock Multifactor Developed International ETF (JHMD) hits a new 52-week high. Are more gains in store?
A Marvelous Multi-Factor Idea For International Equity Exposure
International equities performed admirably in 2019 but still trailed their U.S. rivals. With valuation in markets outside the U.S. still attractive, 2020 could bring out-performance for some developed m...